NIOX Group (LON:NIOX) Issues Quarterly Earnings Results

NIOX Group (LON:NIOX) released its earnings results on Tuesday. The company reported GBX 4.03 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 8.39% and a net margin of 11.30%.

NIOX Group Price Performance

Shares of LON:NIOX traded up GBX 3.40 during trading on Tuesday, hitting GBX 57.80. 3,000,305 shares of the company were exchanged, compared to its average volume of 813,313. The business’s 50 day moving average is GBX 64.53 and its 200-day moving average is GBX 68.35. The company has a market capitalization of £241.57 million, a P/E ratio of 46.24 and a beta of 0.92. The company has a quick ratio of 1.94, a current ratio of 3.73 and a debt-to-equity ratio of 1.86. NIOX Group has a 1-year low of GBX 53.40 and a 1-year high of GBX 77.60.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reduced their price objective on NIOX Group from GBX 90 to GBX 86 and set a “buy” rating on the stock in a research note on Wednesday, January 21st. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of GBX 88.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.